back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 14:39 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,100,000 | |
| Filed 2025-03-20 12:39 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Morris and Associates (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+93,750 vol |
187,500 | |
| Filed 2025-03-20 12:39 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-93,750 vol |
375,000 | |
| Filed 2025-03-20 11:58 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Morris and Associates (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+93,750 vol |
93,750 | |
| Filed 2025-03-20 11:57 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Morris and Associates (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-20 11:57 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-93,750 vol |
305,647 | |
| Filed 2024-12-10 14:10 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+93,750 vol |
399,397 | |
| Filed 2024-12-10 14:10 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-93,750 vol |
468,750 | |
| Filed 2024-12-02 19:34 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+187,500 vol |
305,647 | |
| Filed 2024-12-02 19:34 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-187,500 vol |
562,500 | |
| Filed 2024-08-12 20:06 Tx date 2024-08-12 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,376
+117,647 vol $0.0882 each |
118,147 | |
| Filed 2024-03-01 14:53 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+750,000 vol |
750,000 | |
| Filed 2024-03-01 14:50 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-08 11:31 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,500,000 | ||
| Filed 2021-12-31 12:05 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-23 12:48 Tx date 2023-05-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-118,918.40
-272,000 vol $0.4372 each |
500 | |
| Filed 2023-05-23 12:42 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-375,000 vol |
1,125,000 | |
| Filed 2023-05-23 12:41 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,750
+375,000 vol $0.05 each |
375,000 | |
| Filed 2023-03-28 00:31 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$17,500
+350,000 vol $0.05 each |
||
| Filed 2023-03-28 00:29 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-350,000 vol |